Lale Tokgozoglu

1. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
   2021/08/30 by Frank L J Visseren, Frank L.J. Visseren, François Mach +140 · 56 citations
   Economics, Econometrics and Finance · Medicine · #Cardiac Health and Mental Health #Health Systems, Economic Evaluations, Quality of Life #Lipoproteins and Cardiovascular Health
2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
   2019/08/31 by François Mach, Alberico L. Catapano, Alberico L Catapano +142 · 31 citations
   Economics, Econometrics and Finance · Medicine · #Diabetes, Cardiovascular Risks, and Lipoproteins #Health Systems, Economic Evaluations, Quality of Life #Lipoproteins and Cardiovascular Health
3. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
   2020/01/08 by Jan Borén, M John Chapman, M. John Chapman +48 · 1 voice · 14 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Atherosclerosis and Cardiovascular Diseases #Cancer, Lipids, and Metabolism #Lipoproteins and Cardiovascular Health
4. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
   2023/08/25 by Nikolaus Marx, Massimo Federici, Katharina Schütt +155 · 1 voice · 20 citations
   Medicine · #Diabetes Management and Research #Diabetes Treatment and Management #Pharmacology and Obesity Treatment